Company / Total Debt
ResMed Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$658.4M
FY2025
5-year range
$643.4M / $1.4B
FY2021-FY2025
Trend
-5.6%
vs FY2024
Sector context
#63 of 102
Health Care
What the data says
At $658M, ResMed's total debt ranks #40 of 102 in the Health Care sector. Total Debt has fluctuated over the past 10 years, ranging from $270M in FY2018 to $1.4B in FY2023.
Based on SEC 10-K filings.
$658M in FY2025 with a 5-year CAGR of -10.8%.
Improved from $1.4B to $658M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -4.9%
- 5-Year CAGR
- -10.8%
- 10-Year CAGR
- -
Sector benchmark
#40 of 102 in Health CareTop 38% of 102This company $658.4M Sector average $4.5B
▼
-85.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -10.8%, indicating a declining trend.
- In FY2025, total debt decreased 5.6% year-over-year.
- Ranks #63 out of 102 companies in the Health Care sector.
- Peak total debt was recorded in FY2023.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $658.4M | -5.6% |
| FY2024 | $697.3M | -51.3% |
| FY2023 | $1.4B | +87.0% |
| FY2022 | $765.3M | +19.0% |
| FY2021 | $643.4M | -44.7% |
| FY2020 | $1.2B | -7.5% |
| FY2019 | $1.3B | +366.3% |
| FY2018 | $270.0M | -75.0% |
| FY2017 | $1.1B | +23.5% |
| FY2016 | $873.3M | +190.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026